Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 5:01 PM ET

Date/Time Source News Release
11/20/2024 08:05 AM EST GlobeNewswire Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting
11/13/2024 08:06 AM EST GlobeNewswire Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases
07/16/2024 08:05 AM EDT GlobeNewswire Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
05/21/2024 08:05 AM EDT GlobeNewswire Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
05/14/2024 11:00 AM EDT GlobeNewswire Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
05/08/2024 08:00 PM EDT GlobeNewswire Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
04/15/2024 08:05 AM EDT GlobeNewswire Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
01/25/2024 08:05 AM EST GlobeNewswire Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn's and Colitis Congress
01/09/2024 08:05 AM EST GlobeNewswire Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn's and Colitis Congress
12/06/2023 08:05 AM EST GlobeNewswire Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
Page

Additional News

As of January 3, 2025 • 5:01 PM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Organovo Holdings Inc.
10/25/2024 05:14 PM EDT SeekingAlpha Organovo Holdings files to sell common stock, warrants
07/16/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Tue, Jul 16, 2024 as of 10.00 am ET
05/06/2024 08:26 AM EDT SeekingAlpha GME, ONVO and POAI among pre-market losers
04/18/2024 08:15 AM EDT SeekingAlpha INVO, EZGO and WISA among pre-market losers
04/16/2024 08:28 AM EDT SeekingAlpha INDO, ONVO and HUSA among pre-market losers
04/15/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Mon, Apr 15, 2024 as of 4:00 pm ET
04/15/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Apr 15, 2024 as of 10.00 am ET
04/15/2024 09:05 AM EDT 24/7 Market News Organovo Reports Positive Phase 2 Data for FXR314 in MASH
04/15/2024 08:51 AM EDT SeekingAlpha Organovo reports positive mid-stage results for FXR314 in metabolic dysfunction-associated steatohepatitis
Page